Synopsys Total Revenue vs Capex To Revenue Analysis

SNPS Stock

USD 514.00 8.11 1.55%

Synopsys financial indicator trend analysis is much more than just breaking down Synopsys prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Synopsys is a good investment. Please check the relationship between Synopsys Total Revenue and its Capex To Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synopsys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.

Total Revenue vs Capex To Revenue

Total Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Synopsys Total Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have no relationship.

The correlation between Synopsys' Total Revenue and Capex To Revenue is 0.01. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Synopsys, assuming nothing else is changed. The correlation between historical values of Synopsys' Total Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Synopsys are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Total Revenue i.e., Synopsys' Total Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.01

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Revenue

Total revenue comprises all receipts Synopsys generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Synopsys' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Synopsys current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synopsys. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.At this time, Synopsys' Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 40.53 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 216.2 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	1.7M	1.2M	158.1M	166.1M
Depreciation And Amortization	317.9M	344.8M	396.5M	416.4M

Interest Expense Depreciation And Amortization

Synopsys fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant And Equipment Gross	Good Will	Common Stock Total Equity	Short Term Investments
Total Assets		0.92	0.89	0.99	1.0	0.95	-0.39	0.97	-0.29	0.93	1.0	0.25	0.94	0.95	0.54	0.98	0.92	-0.59	1.0	0.99	0.37	0.5	0.95	0.98	0.63	-0.23
Short Long Term Debt Total	0.92		0.94	0.91	0.9	0.95	-0.12	0.92	-0.51	0.83	0.92	0.18	0.84	0.91	0.33	0.96	0.82	-0.65	0.94	0.91	0.53	0.33	0.95	0.87	0.41	-0.07
Other Current Liab	0.89	0.94		0.86	0.88	0.98	-0.2	0.93	-0.68	0.84	0.87	0.05	0.85	0.84	0.21	0.95	0.87	-0.76	0.9	0.92	0.26	0.25	0.98	0.8	0.3	0.1
Total Current Liabilities	0.99	0.91	0.86		0.98	0.92	-0.37	0.96	-0.22	0.92	0.99	0.22	0.93	0.94	0.56	0.95	0.91	-0.58	1.0	0.98	0.43	0.54	0.92	0.99	0.64	-0.23
Total Stockholder Equity	1.0	0.9	0.88	0.98		0.95	-0.42	0.97	-0.28	0.94	1.0	0.27	0.94	0.94	0.56	0.97	0.92	-0.56	0.99	0.99	0.34	0.5	0.94	0.98	0.64	-0.26
Property Plant And Equipment Net	0.95	0.95	0.98	0.92	0.95		-0.25	0.97	-0.55	0.88	0.94	0.19	0.89	0.92	0.33	0.99	0.91	-0.71	0.95	0.96	0.3	0.32	1.0	0.89	0.43	-0.05
Net Debt	-0.39	-0.12	-0.2	-0.37	-0.42	-0.25		-0.26	-0.15	-0.64	-0.37	-0.03	-0.61	-0.25	-0.74	-0.29	-0.3	-0.21	-0.34	-0.42	0.15	-0.5	-0.24	-0.41	-0.72	0.47
Retained Earnings	0.97	0.92	0.93	0.96	0.97	0.97	-0.26		-0.39	0.87	0.96	0.23	0.89	0.92	0.35	0.97	0.96	-0.75	0.97	0.98	0.29	0.38	0.97	0.93	0.46	-0.05
Accounts Payable	-0.29	-0.51	-0.68	-0.22	-0.28	-0.55	-0.15	-0.39		-0.29	-0.25	0.16	-0.32	-0.27	0.37	-0.45	-0.36	0.57	-0.3	-0.36	-0.01	0.3	-0.57	-0.13	0.31	-0.5
Cash	0.93	0.83	0.84	0.92	0.94	0.88	-0.64	0.87	-0.29		0.92	0.2	0.99	0.84	0.64	0.9	0.83	-0.42	0.92	0.95	0.28	0.53	0.87	0.91	0.71	-0.29
Non Current Assets Total	1.0	0.92	0.87	0.99	1.0	0.94	-0.37	0.96	-0.25	0.92		0.25	0.92	0.95	0.56	0.97	0.91	-0.57	1.0	0.98	0.39	0.52	0.94	0.99	0.64	-0.27
Non Currrent Assets Other	0.25	0.18	0.05	0.22	0.27	0.19	-0.03	0.23	0.16	0.2	0.25		0.19	0.28	0.14	0.21	0.23	-0.08	0.22	0.24	0.2	-0.01	0.19	0.26	0.21	-0.19
Cash And Short Term Investments	0.94	0.84	0.85	0.93	0.94	0.89	-0.61	0.89	-0.32	0.99	0.92	0.19		0.84	0.6	0.9	0.86	-0.46	0.93	0.96	0.31	0.52	0.88	0.91	0.68	-0.21
Net Receivables	0.95	0.91	0.84	0.94	0.94	0.92	-0.25	0.92	-0.27	0.84	0.95	0.28	0.84		0.48	0.93	0.8	-0.56	0.95	0.93	0.4	0.41	0.91	0.94	0.56	-0.27
Common Stock Shares Outstanding	0.54	0.33	0.21	0.56	0.56	0.33	-0.74	0.35	0.37	0.64	0.56	0.14	0.6	0.48		0.41	0.32	0.31	0.52	0.5	0.34	0.79	0.3	0.64	0.97	-0.78
Non Current Liabilities Total	0.98	0.96	0.95	0.95	0.97	0.99	-0.29	0.97	-0.45	0.9	0.97	0.21	0.9	0.93	0.41		0.9	-0.67	0.98	0.97	0.33	0.39	0.99	0.94	0.5	-0.13
Other Current Assets	0.92	0.82	0.87	0.91	0.92	0.91	-0.3	0.96	-0.36	0.83	0.91	0.23	0.86	0.8	0.32	0.9		-0.76	0.92	0.93	0.22	0.4	0.91	0.87	0.43	0.02
Other Stockholder Equity	-0.59	-0.65	-0.76	-0.58	-0.56	-0.71	-0.21	-0.75	0.57	-0.42	-0.57	-0.08	-0.46	-0.56	0.31	-0.67	-0.76		-0.61	-0.62	-0.01	0.04	-0.72	-0.48	0.17	-0.5
Total Liab	1.0	0.94	0.9	1.0	0.99	0.95	-0.34	0.97	-0.3	0.92	1.0	0.22	0.93	0.95	0.52	0.98	0.92	-0.61		0.99	0.4	0.5	0.95	0.98	0.6	-0.2
Total Current Assets	0.99	0.91	0.92	0.98	0.99	0.96	-0.42	0.98	-0.36	0.95	0.98	0.24	0.96	0.93	0.5	0.97	0.93	-0.62	0.99		0.32	0.46	0.96	0.96	0.59	-0.17
Short Term Debt	0.37	0.53	0.26	0.43	0.34	0.3	0.15	0.29	-0.01	0.28	0.39	0.2	0.31	0.4	0.34	0.33	0.22	-0.01	0.4	0.32		0.25	0.29	0.41	0.34	-0.21
Intangible Assets	0.5	0.33	0.25	0.54	0.5	0.32	-0.5	0.38	0.3	0.53	0.52	-0.01	0.52	0.41	0.79	0.39	0.4	0.04	0.5	0.46	0.25		0.31	0.55	0.84	-0.53
Property Plant And Equipment Gross	0.95	0.95	0.98	0.92	0.94	1.0	-0.24	0.97	-0.57	0.87	0.94	0.19	0.88	0.91	0.3	0.99	0.91	-0.72	0.95	0.96	0.29	0.31		0.88	0.4	-0.03
Good Will	0.98	0.87	0.8	0.99	0.98	0.89	-0.41	0.93	-0.13	0.91	0.99	0.26	0.91	0.94	0.64	0.94	0.87	-0.48	0.98	0.96	0.41	0.55	0.88		0.7	-0.35
Common Stock Total Equity	0.63	0.41	0.3	0.64	0.64	0.43	-0.72	0.46	0.31	0.71	0.64	0.21	0.68	0.56	0.97	0.5	0.43	0.17	0.6	0.59	0.34	0.84	0.4	0.7		-0.72
Short Term Investments	-0.23	-0.07	0.1	-0.23	-0.26	-0.05	0.47	-0.05	-0.5	-0.29	-0.27	-0.19	-0.21	-0.27	-0.78	-0.13	0.02	-0.5	-0.2	-0.17	-0.21	-0.53	-0.03	-0.35	-0.72

Click cells to compare fundamentals

Synopsys Account Relationship Matchups

Synopsys fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	8.0B	8.8B	9.4B	10.3B	11.9B	12.5B
Short Long Term Debt Total	663.5M	666.8M	656.4M	687.8M	791.0M	830.5M
Other Current Liab	576.1M	640.1M	828.8M	741.1M	852.3M	894.9M
Total Current Liabilities	2.1B	2.4B	2.8B	3.0B	3.4B	3.6B
Total Stockholder Equity	4.9B	5.3B	5.5B	6.1B	7.1B	7.4B
Property Plant And Equipment Net	949.6M	965.6M	1.0B	1.1B	1.3B	1.4B
Net Debt	(572.2M)	(766.1M)	(761.2M)	(751.1M)	(676.0M)	(709.8M)
Retained Earnings	3.8B	4.5B	5.5B	6.7B	7.8B	8.1B
Accounts Payable	30.0M	27.4M	37.6M	155.9M	179.3M	197.9M
Cash	1.2B	1.4B	1.4B	1.4B	1.7B	1.7B
Non Current Assets Total	5.5B	5.9B	6.4B	6.9B	7.9B	8.3B
Non Currrent Assets Other	406.0M	492.3M	(953.9M)	471.0M	541.6M	568.7M
Cash And Short Term Investments	1.2B	1.6B	1.6B	1.6B	1.8B	1.9B
Net Receivables	995.3M	568.5M	796.1M	947.0M	1.1B	1.1B
Common Stock Shares Outstanding	155.7M	157.3M	156.5M	155.2M	155.9M	146.7M
Liabilities And Stockholders Equity	8.0B	8.8B	9.4B	10.3B	11.9B	12.5B
Non Current Liabilities Total	977.8M	1.0B	1.1B	1.2B	1.3B	1.4B
Other Current Assets	125.9M	430.0M	439.1M	567.5M	652.6M	685.3M
Other Stockholder Equity	1.2B	793.5M	214.2M	(399.5M)	(459.4M)	(436.5M)
Total Liab	3.1B	3.5B	3.9B	4.1B	4.8B	5.0B
Total Current Assets	2.5B	2.8B	3.0B	3.4B	3.9B	4.1B
Short Term Debt	173.4M	234.3M	108.5M	155.2M	178.5M	93.6M
Intangible Assets	254.3M	279.1M	386.4M	374.2M	430.3M	324.9M
Property Plant And Equipment Gross	949.6M	965.6M	1.0B	1.1B	1.3B	1.4B
Accumulated Other Comprehensive Income	(54.1M)	(49.6M)	(234.3M)	(196.4M)	(176.8M)	(167.9M)
Good Will	3.4B	3.6B	3.8B	4.1B	4.7B	4.9B
Common Stock Total Equity	1.5M	1.5M	1.5M	1.5M	1.8M	1.5M
Common Stock	1.5M	1.5M	1.5M	1.5M	1.7M	1.5M
Other Liab	443.7M	414.5M	527.7M	482.3M	554.6M	280.2M
Other Assets	775.2M	898.6M	1.1B	1.1B	1.3B	1.4B
Long Term Debt	100.8M	25.1M	20.8M	18.1M	20.8M	19.8M
Treasury Stock	(597.7M)	(625.6M)	(488.6M)	(782.9M)	(704.6M)	(669.4M)
Property Plant Equipment	429.5M	483.8M	965.6M	1.0B	1.2B	1.3B
Current Deferred Revenue	1.4B	1.5B	1.9B	1.8B	2.0B	2.1B
Inventory	192.3M	229.0M	211.9M	325.6M	374.4M	393.1M
Net Tangible Assets	632.5M	1.3B	1.4B	1.3B	1.5B	1.6B
Retained Earnings Total Equity	3.2B	3.8B	4.5B	5.5B	6.4B	6.7B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Synopsys Stock Analysis

When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC